References
M.J.H. Smith andP.D. Dawkins,Salicylate and enzymes, J. Pharm. Pharmac.23, 729–744 (1971).
R.J. Flower andJ.R. Vane,Inhibition of prostaglandin biosynthesis, Biochem. Pharmac.23, 1439–1450 (1974).
T.Y. Shen, S.-B. Hwang, M.N. Chang, T.W. Doebber, M.-H.T. Lam, M.S. Wu, X. Wang, G.Q. Han andR.Z. Li,Characterization of a plateletactivating factor receptor antagonist isolated from haifenteng (Piper futokadsura):Specific inhibition of in vitroand in vivoplatelet-activating factor-induced effects, Proc. natl. Acad. Sci. USA,82, 672–676.
S. Leyck, E. Etschenberg, U. Hadding andJ. Winkelmann,A new model of acute inflammation: Cobra venom factor induced paw oedema, Agents and Actions13, 437–438 (1983).
M.J. Parnham, H. Borbe, P. Kuhl andS. Leyck,Ebselen and other lipoxygenase inhibitors: comparative inhibition of arachidonate oxygenation and cobra venom factor oedema, Int. J. Immunopharmac.,7, 394.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parnham, M.J. Chairman's introduction Determinants of inflammation test selection:In vitro orin vivo?. Agents and Actions 17, 327–328 (1986). https://doi.org/10.1007/BF01982637
Issue Date:
DOI: https://doi.org/10.1007/BF01982637